Convexity Labs

CVV

Convexity Analyst · CVV
Speculativelow confidenceTactical · no named thesis
Generated Jun 21, 2026

ANALYST NOTE: CVV (CVD Equipment Corporation) Date: 2026-06-13 Current Price: $7.81

1. Structural Readiness

Conservative Entry: — (Not yet triggered; requires a confirmed breakout above the defined resistance level) Aggressive/Pre-Breakout Entry: — (Not actionable on setup alone; requires confirmation) Breakout Level: — (Pending confirmation) Current Price: $7.81 Extension: — (No extension data provided; price is currently in the consolidation/pullback phase of the forming coil)

2. Thesis Layer

Thesis Classification: TACTICAL / SETUP-LED Macro Thesis Status: NONE As of 2026-06-13, there is no named secular macro thesis driving this name. The investment case is strictly tactical, driven by the structural setup quality and specific business fundamentals (cost reduction, asset sale proceeds, backlog stability). We are judging this name on its setup quality and the immediate operational turnaround, not on a broad market cycle or secular growth narrative. Do not invent a thesis; the conviction must rest entirely on the execution of the "Deep Value Recovery" archetype and the structural setup.

3. Business Overview

Company Description: CVD Equipment Corporation designs, develops, and manufactures sophisticated process equipment and comprehensive solutions for the development and production of materials and coatings. Industry: Industrials (Specialized Equipment / Advanced Materials). Business Model: The company operates through three distinct divisions: CVD (Chemical Vapor Deposition Systems), SDC (Silicon Diamond Coatings), and CVD Materials. Key Operations & Evidence (as of 2026-06-13):

  • Strategic Restructuring: The company has executed a major pivot. On March 23, 2026, CVD announced the sale of its SDC business division to Atlas Copco for approximately $16.9 million in cash. This transaction closed on April 1, 2026 (per E4, E11).
  • Balance Sheet Impact: Immediately following the SDC sale, the company reported approximately $23 million in cash and no long-term debt (E8). This provides a significant liquidity buffer.
  • Cost Reduction: A workforce reduction in the CVD Equipment division during Q4 2025 is expected to reduce annual operating costs by approximately $1.8 million in 2026 (E3).
  • Backlog & Orders:
  • As of March 31, 2026, the backlog was $4.7 million, similar to the December 31, 2025 level (E1).
  • Q1 2026 orders totaled $1.8 million, driven primarily by demand for spare parts (E2).
  • *Contrast:* This represents a significant contraction from prior periods. 2025 bookings were $13.0 million (down 53.7% from 2024's $28.1 million) (E9). Backlog as of Dec 31, 2025, was $6.6 million, down from $19.4 million in 2024 (E10).
  • Customer Concentration: Revenue remains highly concentrated. In Q1 2026, three key customers represented 66% of total revenue (E6). In 2025, two customers represented 27.6% and 13.7% of revenue (E13).
  • Market Focus: The company serves aerospace, defense, industrial applications (silicon carbide on graphite, high-power electronics), and emerging sectors like nuclear energy (E5). They are seeing RFQs (Request for Quotes) coming in at a higher rate than in 2025 (E7).

4. Archetype and Conviction Stack

Archetype: Deep Value Recovery Rationale: The name fits the "Deep Value Recovery" archetype due to the combination of a distressed prior period (53.7% drop in bookings, massive backlog drawdown) followed by a strategic asset sale (SDC to Atlas Copco) that has cleansed the balance sheet (cash position, zero debt) and initiated a cost-cutting program ($1.8M annual savings). The "recovery" thesis relies on the stabilization of the remaining CVD division and the potential for the new cash position to fund growth or M&A, rather than organic top-line explosion immediately.

Conviction Stack Analysis:

  • Thesis Strength: Low/Medium. The thesis is tactical and lacks a named secular driver. It relies on a "turnaround" narrative which is inherently binary.
  • Evidence Quality: Medium. The evidence is strong on the *structural* changes (sale closed, cash on hand, cost cuts) but weak on *growth* momentum (backlog is down, orders are low). The "RFQs coming in at a higher rate" (E7) is a leading indicator but not yet reflected in revenue or backlog.
  • Structural Quality: Mixed. The balance sheet is now strong ($23M cash, no debt), but the top-line momentum is negative. The "Deep Value" aspect is supported by the cash position relative to the market cap, but the "Recovery" is unproven.
  • Setup Readiness: Partial. The setup is "Forming." The price is holding, but the breakout has not fired. The Extreme ATR (11.3%) is a significant negative factor for setup quality, suggesting high volatility and a higher probability of false breakouts or severe drawdowns if the structure fails.
  • Rerating Potential: Moderate. If the company can demonstrate that the RFQs convert to orders and the backlog stabilizes or grows, the market may re-rate the stock from a "distressed turnaround" to a "stable niche player." However, the current consensus EPS is negative (-0.03), limiting immediate multiple expansion.

5. Invalidations, Strengths, and Gaps

What Would Invalidate the Case:

  • Fundamental: A further significant decline in backlog or a failure to convert the reported higher RFQ rate into actual orders in the next quarter.
  • Operational: Inability to realize the $1.8M cost savings or unexpected cash burn.

What Would Strengthen the Case:

  • Technical: A confirmed breakout above the resistance level (breakout fired) with volume, establishing a new higher low.
  • Fundamental: Evidence of backlog growth (moving above the $4.7M level) or a significant increase in order intake driven by the RFQs mentioned in E7.
  • Strategic: Announcement of new strategic initiatives funded by the $23M cash position.

Gaps in Evidence Base:

  • Forward Guidance: No specific guidance on 2026 full-year revenue or EPS targets was provided in the transcript excerpts.
  • Conversion Rate: While RFQs are up (E7), there is no data on the conversion rate of these RFQs to booked orders.
  • Customer Retention: No data on whether the high customer concentration (66% in Q1) is stable or if there is churn risk.
  • Valuation Metrics: No P/S or P/B ratios are provided in the evidence, making a precise valuation comparison difficult.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: low Key evidence: Sale of SDC division closed for $16.9M cash resulting in $23M total cash and zero debt; Workforce reduction expected to save $1.8M annually in 2026; RFQs reported at higher rates than 2025. Key risks: Extreme ATR of 11.3% indicates severe volatility and high failure rate for setups; Backlog and bookings down >50% year-over-year; High customer concentration (66% of Q1 revenue from 3 customers); No named secular thesis to support rerating. Sizing hint: Position size must be minimal due to extreme volatility and lack of confirmed breakout; treat as a high-risk observation rather than a core holding. Expected path: Management expects cost savings to flow through in 2026; the company will likely focus on converting the increased RFQs into orders to stabilize the $4.7M backlog; the setup requires a confirmed price breakout to become actionable. Expected horizon: 3 to 6 months to see if the RFQs convert to orders and if the technical structure resolves into a breakout or breakdown.

Loading chart...
Exhibit 1: CVV daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for CVV.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for CVV.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: